# A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.

> **NCT07319897** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Multiple Myeloma
- Multiple Myeloma and Malignant Plasma Cell Neoplasms
- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-BCMA PET/CT

## Key facts

- **NCT ID:** NCT07319897
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319897, "A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07319897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*